跳至主要内容
临床试验/NCT02537730
NCT02537730已完成不适用

BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover Study

Coopervision, Inc.3 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2015年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
3
主要终点
Ocular Health - Corneal Staining

研究概览

简要总结

Two week, Open Label, randomized, bilateral, crossover, 1 week of daily wear in each combination (lens / disinfecting cleaning system).

详细描述

To determine if patients are unreactive to the lens care solution / Biofinity combination. It is expected that there will be a total of three visits: V1 (Initial), V2 (1 week), & V3 (2 weeks).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Is over 18 years of age (inclusive)
  • •Has had a self-reported visual exam in the last two years
  • •Has a CL (contact lens) spherical prescription between -0.25D (Diopters) and -12.00D (inclusive)
  • •Has less than 1.00 D spectacle cylinder in each eye
  • •Is correctable to a visual acuity of 20/20 or better in both eyes
  • •Has clear corneas and no active ocular disease
  • •Has read, understood and signed the informed consent letter
  • •Is willing to comply with the wear schedule (at least 40hrs per week)
  • •Is willing to comply with the visit schedule

排除标准

  • •Has never worn contact lenses before
  • •Currently wears rigid gas permeable contact lens
  • •Has a history of not achieving comfortable CL (contact lens) wear (5 days per week; > 8 hours per day)
  • •Has a CL prescription outside the range of -0.25D to -12.00D
  • •Has a spectacle cylinder greater than -0.75D of cylinder in either eye
  • •Has best corrected spectacle distant vision worse than 20/20 in ether eye
  • •Has any systemic disease affecting ocular health
  • •Is using any systemic or topical medications that will affect ocular health
  • •Has any ocular pathology or sever insufficiency of lacrimal secretion
  • •Has persistent, clinically significant corneal or conjunctival staining
  • •Has active neovascularization or any central corneal scars
  • •Is aphakic
  • •Is pregnant or lactating

研究组 & 干预措施

Bioclean MPS VII / comfilcon A combination

Active Comparator

Participants were randomized to the Bioclean MPS VII / comfilcon A combination for one week during the cross over study.

干预措施: Bioclean MPS VII (Device)

Bioclean MPS VII / comfilcon A combination

Active Comparator

Participants were randomized to the Bioclean MPS VII / comfilcon A combination for one week during the cross over study.

干预措施: comfilcon A (Device)

Aosept Clearcare / comfilcon A combination

Active Comparator

Participants were randomized to the Aosept Clearcare / comfilcon A combination for one week during the cross over study.

干预措施: Aosept Clearcare (Device)

Aosept Clearcare / comfilcon A combination

Active Comparator

Participants were randomized to the Aosept Clearcare / comfilcon A combination for one week during the cross over study.

干预措施: comfilcon A (Device)

结局指标

主要结局

Ocular Health - Corneal Staining

时间窗: 1 week

Corneal staining for Bioclean MPS (Multi-Purpose Solution) VII / comfilcon A combination and Aosept Clearcare / comfilcon A combination assessed by slit lamp. Grade 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe.

次要结局

  • Comfort(1 week)
  • Dryness(1 week)
  • Stinging and Burning Sensation(Baseline)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验